-
1
-
-
0029784466
-
Anti-HIV therapy with antisense oligonucleotides and ribozyme: Realistic approaches or expensive myths?
-
AKHTAR, S., and ROSSI, J.J. (1996). Anti-HIV therapy with antisense oligonucleotides and ribozyme: realistic approaches or expensive myths? J. Antimicrob. Chemother. 38, 159-165.
-
(1996)
J. Antimicrob. Chemother.
, vol.38
, pp. 159-165
-
-
Akhtar, S.1
Rossi, J.J.2
-
2
-
-
0028858581
-
Chemical modification of hammerhead ribozymes. Catalytic activity and nuclease resistance
-
BEIGELMAN, L., McSWIGGEN, J.A., DRAPER, K.G., GONZALEZ, C., JENSEN, K., KARPEISKY, A.M., MODAK, A.S., MATULIC, A.J., DIRENZO, A.B., HAEBERLI, P., SWEEDLER, D., TRACZ, D., GRIMM, S., WINCOTT, RE., THACKRAY, V.G., and USMAN, N. (1995). Chemical modification of hammerhead ribozymes. Catalytic activity and nuclease resistance. J. Biol. Chem. 270, 25702-25708.
-
(1995)
J. Biol. Chem.
, vol.270
, pp. 25702-25708
-
-
Beigelman, L.1
McSwiggen, J.A.2
Draper, K.G.3
Gonzalez, C.4
Jensen, K.5
Karpeisky, A.M.6
Modak, A.S.7
Matulic, A.J.8
Direnzo, A.B.9
Haeberli, P.10
Sweedler, D.11
Tracz, D.12
Grimm, S.13
Wincott, R.E.14
Thackray, V.G.15
Usman, N.16
-
3
-
-
0019856947
-
In vitro splicing of the ribosomal RNA precursor of Tetrahymena: Involvement of a guanosine nucleotide in the excision of the intervening sequence
-
CECH, T.R., ZAUG, A.J., and GRABOWSKI, P.J. (1981). In vitro splicing of the ribosomal RNA precursor of Tetrahymena: Involvement of a guanosine nucleotide in the excision of the intervening sequence. Cell 27, 487-496.
-
(1981)
Cell
, vol.27
, pp. 487-496
-
-
Cech, T.R.1
Zaug, A.J.2
Grabowski, P.J.3
-
4
-
-
0026779558
-
Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication - Potential effectiveness against most presently sequenced HIV-1 isolates
-
CHEN, C.J., BANERJEA, A.C., HARMISON, G.G., HAGLUND, K., and SCHUBERT, M. (1992). Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication - Potential effectiveness against most presently sequenced HIV-1 isolates. Nucleic Acids Res. 20, 4581-4589.
-
(1992)
Nucleic Acids Res.
, vol.20
, pp. 4581-4589
-
-
Chen, C.J.1
Banerjea, A.C.2
Harmison, G.G.3
Haglund, K.4
Schubert, M.5
-
5
-
-
0028842207
-
Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes
-
CONNOR, R.I., CHEN, B.K., CHOE, S., and LANDAU, N.R. (1995). Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206, 935-944.
-
(1995)
Virology
, vol.206
, pp. 935-944
-
-
Connor, R.I.1
Chen, B.K.2
Choe, S.3
Landau, N.R.4
-
6
-
-
0031906149
-
Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines
-
CORNOR, R.I., KORBER, B.T.M., GRAHAM, B.S., HAHA, B.H., HO, D.D., WALKER, B.D., NEUMANN, A.U., VERMUND, S.H., MESTECKY, J., JACKSON, S., FENAMORE, E., CAO, Y., GAO, F., KALAMS, S., KUNSTMAN, K.J., McDONALD, D., McWILLIAMS, N., TRKOLA, A., MOORE, J.P., and WOLINSKY, S.M. (1998). Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines. J Virol. 72, 1552-1576.
-
(1998)
J Virol.
, vol.72
, pp. 1552-1576
-
-
Cornor, R.I.1
Korber, B.T.M.2
Graham, B.S.3
Haha, B.H.4
Ho, D.D.5
Walker, B.D.6
Neumann, A.U.7
Vermund, S.H.8
Mestecky, J.9
Jackson, S.10
Fenamore, E.11
Cao, Y.12
Gao, F.13
Kalams, S.14
Kunstman, K.J.15
McDonald, D.16
McWilliams, N.17
Trkola, A.18
Moore, J.P.19
Wolinsky, S.M.20
more..
-
7
-
-
15844419153
-
Identification of a major co-receptor for primary isolates of HIV-1
-
DENG, H., LIU, R., ELLMEIER, W., CHOE, S., UNUTMAZ, D., BURKHART, M., DI, M.P., MARMON, S., SUTTON, R.E., HILL, C.M., DAVIS, C.B., PEIPER, S.C., SCHALL, T.J., LITTMAN, D.R., and LANDAU, N.R. (1996). Identification of a major co-receptor for primary isolates of HIV-1. Nature 381, 661-666.
-
(1996)
Nature
, vol.381
, pp. 661-666
-
-
Deng, H.1
Liu, R.2
Ellmeier, W.3
Choe, S.4
Unutmaz, D.5
Burkhart, M.6
Di, M.P.7
Marmon, S.8
Sutton, R.E.9
Hill, C.M.10
Davis, C.B.11
Peiper, S.C.12
Schall, T.J.13
Littman, D.R.14
Landau, N.R.15
-
8
-
-
10544234615
-
Optimizing the cell efficacy of synthetic ribozymes. Site selection and chemical modifications of ribozymes targeting the proto-oncogene c-myb
-
JARVIS, T.C., WINCOTT, F.E., ALBY, L.J., McSWIGGEN, J.A., BEIGELMAN, L., GUSTOFSON, J., DIRENZO, A., LEVY, K., ARTHUR, M., MATULIC, A.J., KARPEISKY, A., GONZALEZ, C., WOOLF, T.M., USMAN, N., and STINCHCOMB, D.T. (1996). Optimizing the cell efficacy of synthetic ribozymes. Site selection and chemical modifications of ribozymes targeting the proto-oncogene c-myb. J. Biol. Chem. 271, 29107-29112.
-
(1996)
J. Biol. Chem.
, vol.271
, pp. 29107-29112
-
-
Jarvis, T.C.1
Wincott, F.E.2
Alby, L.J.3
McSwiggen, J.A.4
Beigelman, L.5
Gustofson, J.6
Direnzo, A.7
Levy, K.8
Arthur, M.9
Matulic, A.J.10
Karpeisky, A.11
Gonzalez, C.12
Woolf, T.M.13
Usman, N.14
Stinchcomb, D.T.15
-
9
-
-
0005150171
-
The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter
-
KATZENSTEIN, D.A., HAMMER, S.M., HUGHES, M.D., GUNDACKER, H., JACKSON, J.B., FISCUS, S., RASHEED, S., ELBEIK, T., REICHMAN, R., JAPOUR, A., MERIGAN, T.C., and HIRSCH, M.S. (1996). The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. N. Engl. J. Med. 335, 1091-1098.
-
(1996)
N. Engl. J. Med.
, vol.335
, pp. 1091-1098
-
-
Katzenstein, D.A.1
Hammer, S.M.2
Hughes, M.D.3
Gundacker, H.4
Jackson, J.B.5
Fiscus, S.6
Rasheed, S.7
Elbeik, T.8
Reichman, R.9
Japour, A.10
Merigan, T.C.11
Hirsch, M.S.12
-
10
-
-
0028876680
-
Intracellular immunization of human fetal cord blood stem/progenitor cells with a ribozyme against human immunodeficiency virus type 1
-
YU, M., POESCHLA, E., and WONG, S.F. (1995). Intracellular immunization of human fetal cord blood stem/progenitor cells with a ribozyme against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 92, 699-703.
-
(1995)
Proc. Natl. Acad. Sci. USA
, vol.92
, pp. 699-703
-
-
Yu, M.1
Poeschla, E.2
Wong, S.F.3
-
11
-
-
17144447773
-
Phosphorothiolate ribozyme against the conserved sequence in V3 loop of HIV-1
-
ZHANG, X., YAMADA, R., SHIMAYAMA, T., IMADA, K., UCHIYAMA, T., and HATTORI, T. (1996). Phosphorothiolate ribozyme against the conserved sequence in V3 loop of HIV-1. Biochem. Biophys. Res. Commun. 229, 466-471.
-
(1996)
Biochem. Biophys. Res. Commun.
, vol.229
, pp. 466-471
-
-
Zhang, X.1
Yamada, R.2
Shimayama, T.3
Imada, K.4
Uchiyama, T.5
Hattori, T.6
|